Singular Genomics Systems (OMIC)
(Real Time Quote from BATS)
$7.05 USD
0.00 (0.00%)
Updated Aug 8, 2024 09:50 AM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
OMIC 7.05 0.00(0.00%)
Will OMIC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OMIC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OMIC
Similar Genomics Systems (OMIC) Reports Q1 Loss, Lags Revenue Estimates
Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates
OMIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher
Other News for OMIC
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Singular Genomics Systems trading resumes
Singular Genomics Systems trading halted, volatility trading pause
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023